C
Cyclopharm Ltd
ASX:CYC
Cyclopharm Ltd
ASX:CYC
Price:
1.75 AUD
Market Closed
Updated:
Apr 29, 2024
Cyclopharm Ltd
Cash from Investing Activities
|
Cyclopharm Ltd
Cash from Investing Activities Peer Comparison
Comparables:
NTI
IPD
COH
OIL
EMV
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Cash from Investing Activities
-AU$538k
|
CAGR 3-Years
15%
|
CAGR 5-Years
17%
|
CAGR 10-Years
3%
|
|
|
Neurotech International Ltd
ASX:NTI
|
Cash from Investing Activities
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Cash from Investing Activities
-AU$5m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-53%
|
|
|
Cochlear Ltd
ASX:COH
|
Cash from Investing Activities
-AU$87.9m
|
CAGR 3-Years
18%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-10%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Cash from Investing Activities
-AU$5m
|
CAGR 3-Years
-474%
|
CAGR 5-Years
-77%
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Cash from Investing Activities
-AU$187.3k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cyclopharm Ltd's Cash from Investing Activities?
Cash from Investing Activities
-538k
AUD
-538k
AUD
Based on the financial report for Dec 31, 2023, Cyclopharm Ltd's Cash from Investing Activities amounts to -538k AUD.
What is Cyclopharm Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
3%
3%
Over the last year, the Cash from Investing Activities growth was 65%. The average annual Cash from Investing Activities growth rates for Cyclopharm Ltd have been 15% over the past three years , 17% over the past five years , and 3% over the past ten years .
You don't have any saved screeners yet
